MediciNova Receives Notice Of Decision To Grant For New Patent Covering MN-166 (Ibudilast) For Treatment Of Progressive MS In Europe
MedicinoVa 收到決定批准新專利的通知,該專利涉及 MN-166(Ibudilast),用於治療歐洲進行性多發性硬化症
MediciNova Receives Notice Of Decision To Grant For New Patent Covering MN-166 (Ibudilast) For Treatment Of Progressive MS In Europe
MedicinoVa 收到決定批准新專利的通知,該專利涉及 MN-166(Ibudilast),用於治療歐洲進行性多發性硬化症
使用瀏覽器的分享功能,分享給你的好友吧